Exam 3 Clinical Correlates Flashcards

1
Q

Glycolysis defects

A
  • pyruvate kinase deficiency
    -galactosemia
    -fructose and galactose mutations
    -essential Fructossura
    -hereditary fructose intolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pyruvate Kinase Deficiency

A

-lack of Atp –> hemolytic anemia
-jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fructose and galactose mutations

A

-recessive inheritance
-failure to thrive
-multi-organ involvement triggered by offending food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Essential Fructosuria

A

-fructokinase deficiency does not enter the liver
-excessive fructose in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hereditary fructose intolerance

A

-Aldolase B deficiency
-FIP trapped in liver
-depletes phosphate
-inhibits glycogen mobilization (hypoglycemia)
-liver damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Galactosemia

A

-galactose 1 phosphate uridyltransferase deficiency
-galactose 1 phosphates accululate in liver, cns, kidney (diarrhea, jaundice, vomiting)
-UDP galactose epimerase deficiency
-galactokinase deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mitochondrial effects

A

-DNP
-MERF
-MELAS
-combined oxidative phos. deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DNP

A

-uncoupling
-collapses proton gradient and bypasses ATP synthase
-hyperthermia, tachycardia, diaphoresis, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MERF

A

-point mutation in trna for lysine
-myoclonus
-ataxia
-seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MELAS

A

-mutation in trna for leucine
-mitochondrial myopathy enoephalopathy
-lactic acidosis
-stroke like episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Combined oxidative phos. deficiency

A
  1. mutation in mitochondrial elongation
  2. mutation in ribosomal protein s16
    -metabolic acidosis
    -microcephaly
    -liver dysfunction
    -growth retardation
    -encephalopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

BeriBeri

A

-thiamine deficiency
-pain and parathesia
-wet - CHF and peripheral edema
-dry - symmetrical peripherial neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Wernickes encephalopathy

A

-thiamine deficiency, alcoholism
-mental impairment, cerebellar ataxia, opthalmoplega
-can be treated with thiamine
-can lead to koraskoff which is severe learning defect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chronic lactic acidosis

A

-pyruvate dehydrogenase deficiency
-severe neuro defects
-mutations in E1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fumarase deficiency

A

-elevated urine fumarate
-neuro impairment
-lactic acidemia
-dystonia
-encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Glucogenesis disorder

A
  • ex. F 1,6 BP deficiency
    -pre disposed to fasting hypoglycemia
    -pyruvate/lactate accumulate in blood (metabolic acidosis)
    -liver converts then to fat (fatty liver)
17
Q

PPP disorder

A
  • ex. G6P dehydrogenase deficiency
  • predisposed to hemolytic anemia (triggered by radical stress)
    -cause jaundice and enlarged spleen
    -G6P = x linked and triggered by h202
18
Q

Glycogen storage

A

-GSD 1/ VonGierke
-GSD 2 - Pompe
- GSD V = Mcardles

19
Q

GSD 1/ VonGierke

A

-affects the liver –> cant release glucose during fasting
-fasting hypoglycemia
-enlarged liver
-metabolic acidosis (lactate accumulates)

20
Q

GSD 2 - Pompe

A

-lysosomal alpha glucokinase defect
-lysosomal storage disease
-enlarged heart and liver
-affects all tissues

21
Q

GSD V = Mcardles

A

-muscle glycogen phosphorylase deficit
-muscle cant mobilize glycogen
-exercise intolerance
cannot produce lactate

22
Q

GAG disorders

A

-Hunter
-Hurler-Schiele
-Sanfilipo
-detect GAGs in urine

23
Q

Hunter disorder

A

-dermatan and heparan sulfate accumulation
-iduronate sulfate enzyme defects
- x linked
-skeletal abnormalities and intellectual disabilities

24
Q

Hurler-Schiele

A

–dermatan and heparan sulfate accumulation
-alpha iduronase defects
-skeletal abnormalities and intellectual disabilities

25
Q

Sanfilipo

A

-heparan sulfate accumulation
-mild physical issues
-severe intellectual disabilities

26
Q

Acute Stress

A
  • triggers release of epi
    -binds adrenergic receptors and signals through camp,pka,ca
    -increase glycogenolysis and glucogenesis in liver
    -increase glycolysis in muscles
27
Q

Chronic Stress

A

-increase in cortisol
-increase in gluconeogenesis and glycogen synthesis
-decrease glucose deposition in adipose tissue
-generate insulin resistance

28
Q

Glucoronic acid disorders

A

-UGT deficiency
-Gilbert
-Crigler-najjar

29
Q

UGT deficiency

A

-lead to non-hemolytic jaundice
-defects in bilirubin excretion (build up of bilirublin)

30
Q

Gilbert deficiency

A

-mostly asymptomatic

31
Q

Crigler-najjar

A

-rare and severe

32
Q

Congenital sucrase/isomaltase deficiency

A

-affects cleavage of sucrose
-diarrhea/gas pain after consuming fruit sugar

33
Q

Lactose non-persistence

A

-no blood sugar increase
-H2 on breath
-early adult onset

34
Q

PKA

A

-activated in response to camp
-mediates response to low serum glucose and suddens stress
-activates glycogenolysis, fatty acid degradation, gluconeogenesis
-supresses
-Glycolysis, glycogen synthesis, FA synthesis
-outcome = Raises serum glucose, initiates fasting response

35
Q

Akt

A

-activated in response to PIP3
-mediates response to high serum glucose, growth factors
-activates Fatty acid, glycogen and protein synthesis, glucose uptake
- suppresses apoptosis
- outcome = Lowers serum glucose, stimulates growth

36
Q

PKC

A
  • activated in response to Diacylglycerol, Ca?+
  • mediates repsonse to various stimuli
  • biochemical effects = Various actions, e.g.
    receptor desensitization, membrane structure changes, smooth muscle contraction
  • outcome = varies between cell types
37
Q

AMPK

A

-activated in response to AMP
-mediates response to low cellular energy
- activates glycogenolysis, glycolysis
- suppresses gluconeogenesis,
Fatty acid and cholesterol synthesis
- outcome = raises cellular ATP